While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys
'Fighting back' Kerry Fulford, a pharmaceutical analyst at Berenberg, told the BBC that this was the "first move Novo Nordisk is making to clamp down on compounding"
Understanding Mounjaro Side Effects Mounjaro is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist
Type 1 diabetes: a disease of developmental origins
Explore our previous blog to discover all the common challenges and side effects of weight loss injections
All aspects of care, including initial evaluations, laboratory testing , follow-up visits, and dose adjustments, are coordinated within one clinic to ensure continuity and close monitoring